Long Non-Coding RNA LUCAT1 Promotes Progression of Thyroid Carcinoma by Reinforcing ADAM10 Expression Through Sequestering microRNA-493

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Lubitz CC, Zhan T, Gunda V, et al. Circulating BRAF(V600E) levels correlate with treatment in patients with thyroid carcinoma. Thyroid. 2018;28(3):328–339. doi:10.1089/thy.2017.032229378474
   PubMed Web of Science ®Google Scholar
• Baloch ZW, LiVolsi VA. Special types of thyroid carcinoma. Histopathology. 2018;72(1):40–52.29239042
   PubMed Web of Science ®Google Scholar
• Wang Q, Shang J, Zhang Y, Zhou Y, Tang L. MiR-451a restrains the growth and metastatic phenotypes of papillary thyroid carcinoma cells via inhibiting ZEB1. Biomed Pharmacother. 2020;127:109901. doi:10.1016/j.biopha.2020.10990132335297
   PubMed Web of Science ®Google Scholar
• Ferreira HJ, Esteller M. Non-coding RNAs, epigenetics, and cancer: tying it all together. Cancer Metastasis Rev. 2018;37(1):55–73.29374363
   PubMed Web of Science ®Google Scholar
• Li CH, Chen Y. Insight into the role of long noncoding RNA in cancer development and progression. Int Rev Cell Mol Biol. 2016;326:33–65.27572126
   PubMed Web of Science ®Google Scholar
• Harrandah AM, Mora RA, Chan EKL. Emerging microRNAs in cancer diagnosis, progression, and immune surveillance. Cancer Lett. 2018;438:126–132. doi:10.1016/j.canlet.2018.09.01930237038
   PubMed Web of Science ®Google Scholar
• Salehi S, Taheri MN, Azarpira N, Zare A, Behzad-Behbahani A. State of the art technologies to explore long non-coding RNAs in cancer. J Cell Mol Med. 2017;21(12):3120–3140.28631377
   PubMed Web of Science ®Google Scholar
• Ergun S, Oztuzcu S. Oncocers: ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways. Tumour Biol. 2015;36(5):3129–3136. doi:10.1007/s13277-015-3346-x25809705
   PubMedGoogle Scholar
• Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the rosetta stone of a hidden RNA language? Cell. 2011;146(3):353–358. doi:10.1016/j.cell.2011.07.01421802130
   PubMed Web of Science ®Google Scholar
• Gao YS, Liu XZ, Zhang YG, Liu XJ, Li LZ. Knockdown of long noncoding RNA LUCAT1 inhibits cell viability and invasion by regulating miR-375 in glioma. Oncol Res. 2018;26(2):307–313. doi:10.3727/096504017X1508806179575629089067
   PubMed Web of Science ®Google Scholar
• Nai Y, Pan C, Hu X, LncRNA MY. LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR-539. Cancer Med. 2020;9(2):757–767. doi:10.1002/cam4.272431789465
   PubMed Web of Science ®Google Scholar
• Luzon-Toro B, Fernandez RM, Martos-Martinez JM, Rubio-Manzanares-Dorado M, Antinolo G, Borrego S. LncRNA LUCAT1 as a novel prognostic biomarker for patients with papillary thyroid cancer. Sci Rep. 2019;9(1):14374.31591432
   PubMed Web of Science ®Google Scholar
• Deng J, Ma M, Jiang W, Zheng L, Cui S. MiR 493 induces cytotoxic autophagy in prostate cancer cells through regulation on PHLPP2. Curr Pharm Biotechnol. 2020;21. doi:10.2174/1389201021666200318120733
   Web of Science ®Google Scholar
• Sakai H, Sato A, Aihara Y, et al. MKK7 mediates miR-493-dependent suppression of liver metastasis of colon cancer cells. Cancer Sci. 2014;105(4):425–430. doi:10.1111/cas.1238024533778
   PubMed Web of Science ®Google Scholar
• Liu F, Zhuang L, Wu R, Li D. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10. J BUON. 2019;24(5):1905–1912.31786854
   PubMed Web of Science ®Google Scholar
• Wu G, Zheng K, Xia S, et al. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and beta-catenin pathway in Hepatocellular Carcinoma. J Exp Clin Cancer Res. 2016;35(1):89. doi:10.1186/s13046-016-0368-127259866
   PubMed Web of Science ®Google Scholar
• Hong YG, Xin C, Zheng H, et al. miR-365a-3p regulates ADAM10-JAK-STAT signaling to suppress the growth and metastasis of colorectal cancer cells. J Cancer. 2020;11(12):3634–3644. doi:10.7150/jca.4273132284760
   PubMed Web of Science ®Google Scholar
• Mahmoudian-Sani MR, Jalali A, Jamshidi M, et al. Long non-coding RNAs in thyroid cancer: implications for pathogenesis, diagnosis, and therapy. Oncol Res Treat. 2019;42(3):136–142. doi:10.1159/00049515130799425
   PubMed Web of Science ®Google Scholar
• Sui F, Ji M, Hou P. Long non-coding RNAs in thyroid cancer: biological functions and clinical significance. Mol Cell Endocrinol. 2018;469:11–22. doi:10.1016/j.mce.2017.07.02028751134
   PubMed Web of Science ®Google Scholar
• Han CG, Huang Y, Qin L. Long non-coding RNA ZFAS1 as a novel potential biomarker for predicting the prognosis of thyroid cancer. Med Sci Monit. 2019;25:2984–2992. doi:10.12659/MSM.91292131012438
   PubMed Web of Science ®Google Scholar
• Jiao X, Lu J, Huang Y, Zhang J, Zhang H, Zhang K. Long non-coding RNA H19 may be a marker for prediction of prognosis in the follow-up of patients with papillary thyroid cancer. Cancer Biomark. 2019;26(2):203–207. doi:10.3233/CBM-19027331403942
   PubMed Web of Science ®Google Scholar
• Dai W, Tian Y, Jiang B, Chen W. Down-regulation of long non-coding RNA AFAP1-AS1 inhibits tumor growth, promotes apoptosis and decreases metastasis in thyroid cancer. Biomed Pharmacother. 2018;99:191–197. doi:10.1016/j.biopha.2017.12.10529331858
   PubMed Web of Science ®Google Scholar
• Zheng A, Song X, Zhang L, et al. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/beta-catenin pathway. J Exp Clin Cancer Res. 2019;38(1):305. doi:10.1186/s13046-019-1315-831300015
   PubMed Web of Science ®Google Scholar
• Wang W, Dong ML, Zhang W, Liu T. Long noncoding LUCAT1 promotes cisplatin resistance of non-small cell lung cancer by promoting IGF-2. Eur Rev Med Pharmacol Sci. 2019;23(12):5229–5234.31298373
   PubMed Web of Science ®Google Scholar
• Yu H, Xu Y, Zhang D, Liu G. Long noncoding RNA LUCAT1 promotes malignancy of ovarian cancer through regulation of miR-612/HOXA13 pathway. Biochem Biophys Res Commun. 2018;503(3):2095–2100. doi:10.1016/j.bbrc.2018.07.16530107913
   PubMed Web of Science ®Google Scholar
• Gu Y, Zhang Z, Yin J, et al. Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1). J Exp Clin Cancer Res. 2017;36(1):114. doi:10.1186/s13046-017-0582-528859669
   PubMed Web of Science ®Google Scholar
• Liang Z, Kong R, He Z, et al. High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1. Oncotarget. 2017;8(29):47389–47399. doi:10.18632/oncotarget.1765028537888
   PubMedGoogle Scholar
• Kleemann M, Schneider H, Unger K, et al. Induction of apoptosis in ovarian cancer cells by miR-493-3p directly targeting AKT2, STK38L, HMGA2, ETS1 and E2F5. Cell Mol Life Sci. 2019;76(3):539–559. doi:10.1007/s00018-018-2958-x30392041
   PubMed Web of Science ®Google Scholar
• Dempsey PJ. Role of ADAM10 in intestinal crypt homeostasis and tumorigenesis. Biochim Biophys Acta Mol Cell Res. 2017;1864(11 Pt B):2228–2239. doi:10.1016/j.bbamcr.2017.07.01128739265
   PubMed Web of Science ®Google Scholar
• Smith TM Jr, Tharakan A, Martin RK. Targeting ADAM10 in Cancer and Autoimmunity. Front Immunol. 2020;11:499.32265938
   PubMed Web of Science ®Google Scholar
• Wetzel S, Seipold L, Saftig P. The metalloproteinase ADAM10: A useful therapeutic target? Biochim Biophys Acta Mol Cell Res. 2017;1864(11 Pt B):2071–2081. doi:10.1016/j.bbamcr.2017.06.00528624438
   PubMed Web of Science ®Google Scholar
• Guo W, Huang J, Lei P, Guo L, Li X. LncRNA SNHG1 promoted HGC-27 cell growth and migration via the miR-140/ADAM10 axis. Int J Biol Macromol. 2019;122:817–823. doi:10.1016/j.ijbiomac.2018.10.21430391432
   PubMed Web of Science ®Google Scholar
• Pencik J, Pham HT, Schmoellerl J, et al. JAK-STAT signaling in cancer: from cytokines to non-coding genome. Cytokine. 2016;87:26–36. doi:10.1016/j.cyto.2016.06.01727349799
   PubMed Web of Science ®Google Scholar
• Cletzer E, Klahn S, Dervisis N, LeRoith T. Identification of the JAK-STAT pathway in canine splenic hemangiosarcoma, thyroid carcinoma, mast cell tumor, and anal sac adenocarcinoma. Vet Immunol Immunopathol. 2020;220:109996. doi:10.1016/j.vetimm.2019.10999631958674
   PubMed Web of Science ®Google Scholar